Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization
Clinical trial NCT05125874 · UNKNOWN
Trial details
- NCT number
- NCT05125874
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-08-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.